V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210037834 | 210012141 | null | null | Curative (C) | 2015-04-03 | 2015-05-14 | Dasatinib | N | N | 210033299 | DASATINIB |
| 210037835 | 210012157 | 1.79 | 112.9 | null | 2016-06-15 | 2016-06-16 | Methotrexate High Dose (3g/m2) | N | N | 210033375 | IDELALISIB |
| 210037836 | 210012223 | 1.85 | null | Curative (C) | 2018-12-24 | 2019-05-08 | CARBOPLATIN + ETOPOSIDE | null | Y | 210033652 | BENDAMUSTINE |
| 210037837 | 210012279 | 1.63 | 52.6 | Curative (C) | 2014-01-02 | 2014-01-30 | Inotuzumab Ozogamicin | Y | N | 210033900 | RIALTO TRIAL |
| 210037838 | 210012303 | 1.86 | 53.6 | Disease modification (D) | null | 2018-02-01 | Carboplatin + Etoposide iv&po | N | N | 210034037 | PONATINIB |
| 210037839 | 210012320 | 0 | null | Curative (C) | 2017-12-09 | 2018-05-12 | Vinblastine weekly | N | N | 210034115 | VINBLASTINE |
| 210037840 | 210021829 | 1.67 | null | Curative (C) | null | 2021-07-11 | Erwinase (Erwinia Asparaginase) | N | N | 210034173 | BEVACIZUMAB |
| 210037841 | 210021835 | 0 | 79.8 | Curative (C) | null | 2019-07-09 | DOXORUBICIN | Y | N | 210034234 | CISPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE |
| 210037842 | 210012397 | 0 | 88.4 | Curative (C) | 2020-08-03 | 2020-08-03 | FCR IV - Cycle 2 onwards | Y | N | 210034702 | PACLITAXEL |
| 210037843 | 210012493 | 1.82 | null | Curative (C) | 2019-03-08 | 2019-09-13 | CARBOPLATIN + LOMUSTINE + VINCRISTINE | N | N | 210035459 | EURO-EWING |
| 210037844 | 210012533 | 1.53 | null | Palliative (P) | 2020-02-23 | 2020-03-29 | PMitCEBO-R | 02 | N | 210035764 | FBC |
| 210037845 | 210012567 | 0 | null | Curative (C) | 2019-06-04 | 2019-12-10 | CARBOPLATIN + VINORELBINE | Y | N | 210035996 | ICE |
| 210037846 | 210021962 | null | null | null | 2017-06-10 | 2018-01-02 | LENALIDOMIDE + dexamethasone | N | null | 210036039 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 210037847 | 210012608 | 1.63 | 70.8 | Curative (C) | null | 2019-01-04 | DARATUMUMAB | Y | N | 210036393 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 210037848 | 210012645 | 1.79 | 61.2 | Palliative (P) | 2019-11-04 | 2019-11-09 | EW Rel rEECur Irinotecan/Temozolomide | N | N | 210036653 | CARBOPLATIN + ETOPOSIDE + VINCRISTINE |
| 210037850 | 210022068 | 1.88 | 76.6 | Curative (C) | 2014-10-14 | 2014-10-23 | CAV | N | Y | 210037370 | OFATUMUMAB |
| 210037851 | 210012846 | 1.85 | 71.3 | null | null | 2018-10-07 | Clofarabine + Cytarabine | N | N | 210037617 | BORTEZOMIB |
| 210037852 | 210038805 | 1.67 | null | Curative (C) | 2015-12-20 | 2016-01-22 | LENALIDOMIDE | N | N | 210037781 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 210037853 | 210027917 | 1.55 | 46 | Curative (C) | 2017-05-25 | 2017-05-25 | Cytarabine intrathecal | 02 | Y | 210038312 | BORTEZOMIB |
| 210037854 | 210033628 | 1.75 | 63 | Curative (C) | 2019-05-06 | 2019-05-11 | LENALIDOMIDE + RITUXIMAB | N | N | 210038669 | LIPOSOMAL CYTARABINE |
| 210037855 | 210013146 | 1.73 | 6.7 | Curative (C) | 2019-04-02 | 2020-05-22 | IDARUBICIN + MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | Y | N | 210039036 | CYTARABINE HIGH DOSE |
| 210037856 | 210022328 | null | 72.8 | Curative (C) | 2019-09-14 | 2019-09-14 | PACLITAXEL | 02 | N | 210039685 | IVAC |
| 210037857 | 210022337 | 1.64 | 99.8 | Curative (C) | 2016-06-27 | 2016-07-10 | FLUDARABINE | N | N | 210039746 | CYCLET |
| 210037858 | 210022410 | null | null | Curative (C) | 2018-07-02 | 2018-07-16 | Depocyte Intrathecal | N | null | 210040628 | BORTEZOMIB |
| 210037859 | 210013494 | 1.78 | 78 | Curative (C) | 2013-08-10 | 2015-10-06 | Mitomycin Intravesical | Y | N | 210041021 | TRASTUZUMAB |
| 210037860 | 210028093 | 1.71 | 112.8 | Curative (C) | 2017-01-09 | 2017-05-14 | VINORELBINE | Y | N | 210041357 | CLARITY TRIAL |
| 210037861 | 210013659 | null | 60.4 | Curative (C) | 2018-07-14 | 2019-02-19 | Lenalidomide 25mg (Cycle 1 to 25) | Y | N | 210042069 | BEVACIZUMAB + IRINOTECAN |
| 210037862 | 210013674 | 1.69 | null | Palliative (P) | 2018-07-26 | 2019-01-24 | IVE-R | N | N | 210000284 | CVD |
| 210037863 | 210013788 | 1.71 | 63.9 | Curative (C) | 2018-12-05 | 2019-01-30 | MERCAPTOPURINE + METHOTREXATE + VINCRISTINE | N | N | 210028705 | UKALL2003 |
| 210037864 | 210014053 | 1.64 | 72.4 | Palliative (P) | 2020-03-26 | 2020-04-18 | CYCLET | Y | N | 210041781 | CYTARABINE |
| 210037865 | 210014082 | 1.89 | 34.4 | Disease modification (D) | 2019-06-11 | 2019-07-11 | Maintenance Therapy ALL | 2 | N | 210034307 | ALL MAINTENANCE |
| 210037866 | 210004305 | 1.74 | 90.1 | Palliative (P) | 2015-06-04 | 2015-09-16 | Temozolomide 200mg/m2 | N | N | 210000122 | TEMOZOLOMIDE |
| 210037869 | 210004761 | 1.89 | 0 | Palliative (P) | 2018-03-25 | 2018-03-26 | TEMOZOLOMIDE | 02 | N | 210002776 | TEMOZOLOMIDE |
| 210037870 | 210017493 | 1.54 | 73.9 | Curative (C) | 2018-09-23 | 2018-12-30 | TEMOZOLOMIDE | 2 | N | 210003544 | TEMOZOLOMIDE |
| 210037871 | 210037327 | null | 60.9 | Palliative (P) | 2017-02-04 | 2017-02-05 | TEMOZOLOMIDE | N | N | 210003740 | TEMOZOLOMIDE |
| 210037872 | 210035787 | 1.74 | 78.7 | Curative (C) | 2017-03-13 | 2017-03-13 | Temozolomide 200mg/m2 | N | null | 210003897 | TEMOZOLOMIDE |
| 210037873 | 210004979 | 1.8 | 99 | Adjuvant (A) | 2018-02-12 | 2018-02-15 | Temozolomide 200mg/m2 | N | N | 210004002 | TEMOZOLOMIDE |
| 210037874 | 210017539 | 1.73 | 80.85 | null | null | 2017-08-04 | Temozolomide 200mg/m2 | 2 | N | 210004115 | TEMOZOLOMIDE |
| 210037875 | 210005023 | 1.17 | 13.1 | Curative (C) | 2016-04-30 | 2016-10-12 | ALL UKALL2011 Del Int B Pt1 (PAsp) | Y | N | 210004223 | UKALL2011 |
| 210037876 | 210024963 | 0 | 12.8 | Curative (C) | 2018-06-14 | 2018-06-19 | ALL UKALL2011 Del Int C Recon PAsp | Y | null | 210004402 | UKALL2011 |
| 210037877 | 210017578 | 0.89 | 16.3 | Curative (C) | 2014-01-30 | 2014-12-25 | ALL UKALL2011 Del Int C Recon PAsp | Y | N | 210004493 | UKALL2011 |
| 210037878 | 210017581 | 1.88 | 21.1 | Curative (C) | 2016-05-25 | 2016-12-09 | ALL UKALL2011 Del Int A Pt1 (PAsp) | Y | N | 210004496 | UKALL2011 |
| 210037879 | 210017599 | 1.91 | 110 | Curative (C) | 2017-02-07 | 2017-07-26 | ALL UKALL2011 Del Int A Pt1 (PAsp) | 01 | N | 210004715 | UKALL2011 |
| 210037880 | 210032632 | 1.88 | 36.5 | Curative (C) | 2015-09-27 | 2017-05-24 | ALL UKALL2011 Maintenance C2 | Y | N | 210004847 | UKALL2011 |
| 210037881 | 210017630 | 1.86 | 33.4 | Curative (C) | 2018-08-15 | 2018-08-28 | ALL UKALL2011 Aug BFM Cons C PegAsp | Y | null | 210005122 | UKALL2011 |
| 210037882 | 210017633 | 1.21 | null | Curative (C) | 2014-05-31 | 2014-08-05 | ALL UKALL2011 Cap Int Maint C PAsp | Y | null | 210005131 | UKALL2011 |
| 210037883 | 210005206 | 1.82 | 50 | Curative (C) | 2014-05-05 | 2014-11-15 | ALL UKALL2011 Maintenance A1 | N | N | 210005198 | UKALL2011 |
| 210037884 | 210005231 | 1.09 | 15.4 | Curative (C) | 2015-12-24 | 2016-05-27 | ALL UKALL2011 Maintenance A1 | Y | N | 210005288 | UKALL2011 |
| 210037885 | 210005235 | null | 22.4 | Curative (C) | 2014-10-12 | 2015-02-14 | ALL UKALL2011 (ProtM-A) C PegAsp | Y | N | 210005293 | UKALL2011 |
| 210037886 | 210017661 | 0 | 20.4 | Curative (C) | 2018-01-09 | 2018-07-23 | ALL UKALL2011 Del Int C Recon PAsp | Y | N | 210005410 | UKALL2011 |